{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:15:05Z","timestamp":1758816905533},"reference-count":22,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":1211,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[1998,9]]},"abstract":"<jats:p>Various kinds of cells and their mediators are thought to be involved in the pathogenesis of bronchial asthma. However, changes in each mediator or relationship among mediators during an asthmatic attack have not been well documented. In this study, to clarify whether eosinophil protein X (EPX) is a marker which is distinct from leukotriene E<jats:sub>4<\/jats:sub> (LTE<jats:sub>4<\/jats:sub>), or 11\u2010dehydrothromboxane B<jats:sub>2<\/jats:sub> (11DTXB<jats:sub>2<\/jats:sub>), we measured the urinary excretion of EPX, LTE<jats:sub>4<\/jats:sub>, and 11DTXB<jats:sub>2<\/jats:sub> in 14 asthmatics who were admitted to the hospital with either an acute asthmatic attack or status asthmaticus. These patients included eight atopic and six non\u2010atopic types of bronchial asthma, with a median age of 34.0 years. Urinary excretion of EPX was significantly high on admission with the asthmatic attack, and returned to control levels 175 [122 \u2013384]\u2003\u03bcg\/day when the patients were in the improved state (1036\u2013317\u2003\u03bcg\/day, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01). Similar findings were observed in LTE<jats:sub>4<\/jats:sub> (155\u201359\u2003ng\/day, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01) and 11DTXB<jats:sub>2<\/jats:sub> (991\u2013442\u2003ng\/day, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01). No significant differences in values were observed between atopic and non\u2010atopic types of asthma in all three substances. When the individual data during the attack state were analysed, a significant correlation was observed between changes (%) in urinary EPX and those in urinary LTE<jats:sub>4<\/jats:sub>, but no such relationship was observed between changes (%) in urinary EPX and those in urinary 11DTXB<jats:sub>2<\/jats:sub>. These results suggest that measuring urinary EPX levels may be a useful marker for the understanding and management of the disease.<\/jats:p>","DOI":"10.1046\/j.1365-2222.1998.00361.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T09:34:00Z","timestamp":1047375240000},"page":"1138-1144","source":"Crossref","is-referenced-by-count":16,"title":["Correlation among urinary eosinophil protein X, leukotriene E<sub>4<\/sub>, and 11\u2010dehydrothromboxane B<sub>2<\/sub> in patients with spontaneous asthmatic attack"],"prefix":"10.1111","volume":"28","author":[{"family":"Oosaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Mizushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Mita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199010113231505"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/143.3_Pt_2.S66"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)91152-7"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/138.6_Pt_2.S54"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/142.1.91"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(92)90099-N"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1993.tb00895.x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1994.tb00212.x"},{"key":"e_1_2_5_10_2","first-page":"250","article-title":"Eosinophil activity reflects clinical status in patients with asthma before and during a prednisolone course","volume":"75","author":"Skedinger M","year":"1995","journal-title":"Ann Allergy Asthma Immunol"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1995.tb03259.x"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1996.tb00609.x"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)70182-3"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1993.tb00372.x"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0001-706X(93)90063-H"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1997.tb01032.x"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000237697"},{"issue":"1","key":"e_1_2_5_18_2","first-page":"1","article-title":"International consensus report on diagnosis and treatment of asthma","volume":"22","author":"Scheffer AL","year":"1992","journal-title":"Clin Exp Allergy"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(92)90109-K"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.42.6.452"},{"key":"e_1_2_5_21_2","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.4049\/jimmunol.143.7.2317","article-title":"Human eosinophil\u2010derived neurotoxin and eosinophil protein X are likely the same protein","volume":"143","author":"Slifman NR","year":"1989","journal-title":"J Immunol"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.155.2.390"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(91)90408-G"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2222.1998.00361.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2222.1998.00361.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2222.1998.00361.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T05:21:54Z","timestamp":1698470514000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2222.1998.00361.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["10.1046\/j.1365-2222.1998.00361.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2222.1998.00361.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,9]]}}}